New Zealand stocks rose, led by OceanaGold Corp as the price of gold gained when investors were spooked by a downgrade in the outlook for global economic growth. Spark New Zealand, Auckland International Airport and Meridian Energy gained. Metlifecare and other retirement village operators fell as new competitors come to
NZ shares rise led by blue chips
Subscribe to listen
File photo / Getty Images
Blue chip stocks pulled the benchmark index higher in afternoon trading. Meridian, the state-controlled power company, advanced 1 percent to $1.46. Spark, formerly Telecom Corp, rose 0.3 percent to $2.96.
Auckland International Airport gained 0.1 percent to $3.865. Chorus, the telecommunications network operator, climbed 2.7 percent to $1.88. Together the four stocks made up a third of the days total trades.
"When you look at the underlying fundamentals, they remain reasonably supportive. We are seeing low interest rates, modest growth and very low inflation which is generally supportive for equity markets," Solly said.
Yesterday, retirement village operator Regis Healthcare listed on the ASX, netting its owners A$734 million as they sold 71 percent of the company, with shares issued at A$3.65 apiece. The sector is in the midst of a sustained boom, as an ageing population on both sides of the Tasman stokes demand for retirement and respite care.
Oceania Group, a New Zealand-based aged care business, is mulling either a trade sale or possible initial public offering on the NZX. Metlifecare dropped 2 percent to $4.48. Summerset Group Holdings declined 0.4 percent to $2.83. Ryman Healthcare fell 1.1 percent to $7.55.
"They have undoubtedly, over the last five years, been very strong performers," Solly said. "There are some competing investment options starting to emerge."
Air New Zealand was the worst performer on the benchmark index, slipping 2 percent to $1.92.
Kathmandu Holdings fell 0.3 percent to $2.95. The outdoor goods retailer's outgoing chief executive Peter Halkett sold 1.51 million of shares on market yesterday, reaping $4.4 million from the sale.
Outside the benchmark index, SeaDragon, which manufactures fish oil for health supplements, jumped 10 percent to 2.2 cents after it boosted first-half sales 17 percent to $2.45 million, having secured more supply of raw material to bolster production.
The Nelson-based company has building consents for its new refining plant worth $7.5 million.